IL-12 responsiveness and IFN-γ producing cells in a patient with systemic sclerosis
Marco W. Schilham(Leiden University Medical Center), Maarten J. D. van Tol(Leiden University Medical Center), R. Herzberger(Leiden University), Dirk H. J. Verhoeven(Leiden University), Marion A. J. van Rossum(Reade), Jaak M. Vossen(Leiden University Medical Center)
Cited by 0
Related Papers
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
|Annals of the Rheumatic Diseases|2008|220
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
|Arthritis & Rheumatism|1998|217
Predictors of health‐related quality of life in children and adolescents with juvenile idiopathic arthritis: Results from a web‐based survey
|Arthritis Care & Research|2012|155